FDA fast tracks Israeli co PolyPid

PolyPid is developing a localized delayed release antibiotic for treatment of bone infections. Israeli company PolyPid Optimized Therapeutics, which is developing a localized delayed release antibiotic for treatment of bone…

Continue Reading